Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Tecartus led to durable remission in a majority of participants in a Phase II study.
KTE-X19 led to durable remission in a majority of study participants.
Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.